Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.

Published

Journal Article

In an open-label study, 12 patients with refractory MG or who were taking only corticosteroids and required additional immunosuppression received mycophenolate mofetil 1 g twice daily for 6 months. A reduction of three points in a quantified MG score and two points in a manual muscle test or a reduction of 50% in corticosteroid dose defined efficacy. Eight patients improved, beginning after 2 weeks to 2 months. No major side effects were observed.

Full Text

Published version (via Digital Object Identifier)
Pubmed Central version

Duke Authors

Massey, Janice Munn
Sanders, Donald Benjamin

Cited Authors

Ciafaloni, E; Massey, JM; Tucker-Lipscomb, B; Sanders, DB

Published Date

January 2001

Published In

Neurology

Volume / Issue

56 / 1

Start / End Page

97 - 99

PubMed ID

11148243

Pubmed Central ID

11148243

Electronic International Standard Serial Number (EISSN)

1526-632X

International Standard Serial Number (ISSN)

0028-3878

Digital Object Identifier (DOI)

10.1212/wnl.56.1.97

Scholars@Duke